Results 11 to 20 of about 65,159 (298)

Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System [PDF]

Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 2019
Introduction Therapeutic strategies targeting protein aggregations are ready for clinical trials in atypical parkinsonian disorders. Therefore, there is an urgent need for neuroimaging biomarkers to help with the early detection of neurodegenerative ...
Thilo vanEimeren, Angelo Antonini, Daniela Berg, Nico Bohnen, Roberto Ceravolo, Alexander Drzezga, Günter U. Höglinger, Makoto Higuchi, Stephane Lehericy, Simon Lewis, Oury Monchi, Peter Nestor, Matej Ondrus, Nicola Pavese, María Cecilia Peralta, Paola Piccini, José Ángel Pineda‐Pardo, Irena Rektorová, María Rodríguez‐Oroz, Axel Rominger, Klaus Seppi, A. Jon Stoessl, Alessandro Tessitore, Stephane Thobois, Valtteri Kaasinen, Gregor Wenning, Hartwig R. Siebner, Antonio P. Strafella, James B. Rowe, MDS Neuroimaging Study Group and the JPND Working Group ASAP‐SynTau   +29 more
doaj   +2 more sources

Atypical parkinsonian disorders

Chinese Journal of Contemporary Neurology and Neurosurgery, 2011
DOI：10.3969/j.issn.1672-6731.2011.01 ...
Yue HUANG, Shengdi CHEN, Wenning Gregor, et al   +3 more
doaj   +1 more source

Toward Biology-Driven Diagnosis of Atypical Parkinsonian Disorders [PDF]

NeuroSci
Atypical parkinsonian disorders—progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and multiple system atrophy (MSA)—are rare, rapidly progressive neurodegenerative syndromes characterized by distinct molecular pathologies ...
Oscar Arias-Carrión, Elizabeth Romero-Gutiérrez, Emmanuel Ortega-Robles   +2 more
doaj   +2 more sources

TSPO imaging in parkinsonian disorders. [PDF]

Clin Transl Imaging, 2016
Microglial activation is a key aspect of the neuroinflammatory process in neurodegenerative disorders including idiopathic and atypical parkinsonian disorders. With positron emission tomography (PET) it has become possible to image this phenomenon in vivo and over the last years patterns of microglia activation corresponding with the known distribution
Gerhard A.
europepmc   +5 more sources

Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders [PDF]

Turk J Med Sci, 2021
Akdemir ÜÖ, Bora Tokçaer A, Atay LÖ.
europepmc   +3 more sources

Refining the Diagnostic Accuracy of Parkinsonian Disorders using Metaphenomic Annotation of the Clinicopathological Literature

, 2023
Massey Q, Nihoyannopoulos L, Zeidman P, Warner T, Bhatia K, Gandhi S, Lambert C.   +6 more
europepmc   +2 more sources

Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders. [PDF]

Front Aging Neurosci, 2022
Zhang P, Chen J, Cai T, He C, Li Y, Li X, Chen Z, Wang L, Zhang Y.   +8 more
europepmc   +3 more sources

Neuronal entropy depends on the level of alertness in the parkinsonian Globus Pallidus in vivo [PDF]

Frontiers in Neurology, 2014
A new working hypothesis of Parkinson's disease proposes to focus on the central role of entropy increase in the Basal Ganglia in movement disorders. The conditions necessary for entropy increase in vivo are, however, still not fully described.
Daniela Sabrina Andres, Daniela Sabrina Andres, Daniela Sabrina Andres, Daniel eCerquetti, Marcelo eMerello, Ruedi eStoop   +5 more
doaj   +5 more sources

The neurogenetics of atypical parkinsonian disorders. [PDF]

Semin Neurol, 2014
Although classic Parkinson disease is the disorder most commonly associated with the clinical feature of parkinsonism, there is in fact a broader spectrum of disease represented by a collection of phenotypically similar neurodegenerative conditions that mimic many of its core features.
Fogel BL, Clark MC, Geschwind DH.
europepmc   +6 more sources

Integrating tele-palliative care for atypical Parkinsonian disorders: Lessons learned from a pilot program. [PDF]

Clin Park Relat Disord
Afshari M, Kang K, Butala AA, Guenther J, Razzak R, Katz M, Galifianakis NB, Pantelyat A.   +7 more
europepmc   +3 more sources